RegDesk Inc., a leading regulatory intelligence firm founded on the principles of expert-sourcing and networked decisions has announced today that Hans Beinke has joined its Advisory Board. Beinke has an impressive career in regulatory affairs with a focus on developing regulatory systems from the ground up.
“With our focus on building novel intelligence solutions for regulatory teams to predict risks and accelerate global market access, Hans Beinke’s remarkable experience, powerful global network, and guidance will be an asset for our vision,” said Priya Bhutani, CEO and Founder of RegDesk.
“I am thrilled for the opportunity to contribute to the evolution and growth of RegDesk“, said Beinke. “I believe that RegDesk offers a unique and effective approach for their clients to thoroughly evaluate regulatory challenges anywhere in the world.”
Beinke’s vast career in regulatory affairs includes serving as the VP, United States, Healthcare Quality and Technology at Seimens Healthcare, VP of Surgical Products Group at C.R. Bard; COO at Angiosonics, Inc.
Hans also has experience with policy making. He has been an industry representative for numerous FDA committees and initiatives including the FDA Device GMP Advisory Committee and FDA contrast guidance. As an active member of the Medical Imaging and Technology Alliance (MITA), he was the Chair of the Global Affairs Committee and Vice Chair of the Technical and Regulatory Affairs Committee.
RegDesk enables life sciences companies to draw insights from local experts around the world. The fast-growing firm includes in its portfolio Fortune 100 companies and startups. With a global network of experts and tested strategy of swift delivery, RegDesk helps thought leaders see the big picture from multiple vantage points. This disruptive approach has time and again delivered value to its client.